Change in Boardroom
PHARMANIAGA BERHAD |
Date of change | 17 Sep 2019 |
Name | TAN SRI DATO' SERI DR MOHAMED ISMAIL BIN MERICAN |
Age | 71 |
Gender | Male |
Nationality | Malaysia |
Designation | Director |
Directorate | Independent and Non Executive |
Type of change | Resignation |
Reason | To pursue other interest |
Details of any disagreement that he/she has with the Board of Directors | No |
Whether there are any matters that need to be brought to the attention of shareholders | No |
Qualifications
No | Qualifications |
Major/Field of Study |
Institute/University |
Additional Information |
Others
|
Fellow |
American College of Physicians (F.A.C.P) (Hons, US) |
|
|
Degree
|
Bachelor of Medicine, Bachelor of Surgery |
Universiti Malaya |
|
Working experience and occupation | - Tan Sri Dato' Seri Dr Haji Mohamed Ismail is currently the Pro-Chancellor and Chairman of the Board of Governors, MAHSA University. He is also the Consultant Hepatologist Internal Medicine Specialist, Prince Court Medical Centre. -Other senior positions held from 2005 - 2011: -Director-General of Health of Malaysia -President of the Malaysian Medical Council -President of the Malaysian Dental Council -Chairman of Nursing Board -Member of the Promotion Board of the Malaysian Civil Service -Chairman of the National Committee for Clinical Research -Member of the Board of Directors of the National Heart Institute -Chairman of Drug Control Authority -Chairman of National Poisons Board -Chairman of Medicine Advertisement Board -Chairman of Pharmacy Board -Chairman of the Midwives Board Malaysia -Chairman of the Malaysian Optical Council |
Family relationship with any director and/or major shareholder of the listed issuer | Nil |
Any conflict of interests that he/she has with the listed issuer | Nil |
Details of any interest in the securities of the listed issuer or its subsidiaries | Nil |
Announcement Info
Company Name | PHARMANIAGA BERHAD |
Stock Name | PHARMA |
Date Announced | 18 Sep 2019 |
Category | Change in Boardroom |
Reference Number | C03-17092019-00002 |